PositiveID Corp. has received 510(k) clearance from the Food and Drug Administration to market its "iglucose" technology for diabetes management.
The iglucose product enables the transmission of readings from a data-capable glucometer to a diabetes management Web portal where diabetics can gather and track their glucose levels and permit access to family members, caregivers and clinicians. The product eliminates the keeping of paper-based logbooks and helps increase self-management, according to the Delray Beach, Fla.-based vendor.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access